6gnv: Difference between revisions

New page: '''Unreleased structure''' The entry 6gnv is ON HOLD Authors: Robinson, D.A., Harrison, J.R., Brand, S., Smith, V.C., Thompson, S., Smith, A., Davies, K., Mok, N.Y., Torrie, L.S., Colli...
 
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
'''Unreleased structure'''


The entry 6gnv is ON HOLD
==Crystal Structure of Leishmania major N-Myristoyltransferase (NMT) With Bound Myristoyl-CoA and a isopropyl methyl indole aryl sulphonamide ligand==
<StructureSection load='6gnv' size='340' side='right' caption='[[6gnv]], [[Resolution|resolution]] 2.20&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[6gnv]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6GNV OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6GNV FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=F5E:~{N}-[2-methyl-5-(2-methylpropyl)indazol-4-yl]-4-[4-(1-methylpiperidin-4-yl)butyl]benzenesulfonamide'>F5E</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MYA:TETRADECANOYL-COA'>MYA</scene></td></tr>
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Glycylpeptide_N-tetradecanoyltransferase Glycylpeptide N-tetradecanoyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.3.1.97 2.3.1.97] </span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6gnv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6gnv OCA], [http://pdbe.org/6gnv PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6gnv RCSB], [http://www.ebi.ac.uk/pdbsum/6gnv PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6gnv ProSAT]</span></td></tr>
</table>
== Function ==
[[http://www.uniprot.org/uniprot/Q4Q5S8_LEIMA Q4Q5S8_LEIMA]] Adds a myristoyl group to the N-terminal glycine residue of certain cellular proteins (By similarity).
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Crystallography has guided the hybridization of two series of Trypanosoma brucei N-myristoyltransferase (NMT) inhibitors, leading to a novel highly selective series. The effect of combining the selectivity enhancing elements from two pharmacophores is shown to be additive and has led to compounds that have greater than 1000-fold selectivity for TbNMT vs HsNMT. Further optimization of the hybrid series has identified compounds with significant trypanocidal activity capable of crossing the blood-brain barrier. By using CF-1 mdr1a deficient mice, we were able to demonstrate full cures in vivo in a mouse model of stage 2 African sleeping sickness. This and previous work provides very strong validation for NMT as a drug target for human African trypanosomiasis in both the peripheral and central nervous system stages of disease.


Authors: Robinson, D.A., Harrison, J.R., Brand, S., Smith, V.C., Thompson, S., Smith, A., Davies, K., Mok, N.Y., Torrie, L.S., Collie, I., Hallyburton, I., Norval, S., Simeons, F.R.C., Stojanovski, L., Frearson, J.A., Brenk, R., Wyatt, P.G., Gilbert, I.H., Read, K.D.
A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase Inhibitors.,Harrison JR, Brand S, Smith V, Robinson DA, Thompson S, Smith A, Davies K, Mok N, Torrie LS, Collie I, Hallyburton I, Norval S, Simeons FRC, Stojanovski L, Frearson JA, Brenk R, Wyatt PG, Gilbert IH, Read KD J Med Chem. 2018 Sep 12. doi: 10.1021/acs.jmedchem.8b00884. PMID:30207721<ref>PMID:30207721</ref>


Description: Crystal Structure of Leishmania major N-Myristoyltransferase (NMT) With Bound Myristoyl-CoA and a isopropyl methyl indole aryl sulphonamide ligand
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
[[Category: Unreleased Structures]]
</div>
[[Category: Harrison, J.R]]
<div class="pdbe-citations 6gnv" style="background-color:#fffaf0;"></div>
[[Category: Read, K.D]]
== References ==
[[Category: Norval, S]]
<references/>
[[Category: Smith, V.C]]
__TOC__
</StructureSection>
[[Category: Glycylpeptide N-tetradecanoyltransferase]]
[[Category: Brand, S]]
[[Category: Brenk, R]]
[[Category: Brenk, R]]
[[Category: Smith, A]]
[[Category: Robinson, D.A]]
[[Category: Simeons, F.R.C]]
[[Category: Collie, I]]
[[Category: Collie, I]]
[[Category: Mok, N.Y]]
[[Category: Brand, S]]
[[Category: Davies, K]]
[[Category: Davies, K]]
[[Category: Torrie, L.S]]
[[Category: Frearson, J A]]
[[Category: Gilbert, I.H]]
[[Category: Gilbert, I H]]
[[Category: Frearson, J.A]]
[[Category: Hallyburton, I]]
[[Category: Hallyburton, I]]
[[Category: Harrison, J R]]
[[Category: Mok, N Y]]
[[Category: Norval, S]]
[[Category: Read, K D]]
[[Category: Robinson, D A]]
[[Category: Simeons, F R.C]]
[[Category: Smith, A]]
[[Category: Smith, V C]]
[[Category: Stojanovski, L]]
[[Category: Stojanovski, L]]
[[Category: Wyatt, P.G]]
[[Category: Thompson, S]]
[[Category: Thompson, S]]
[[Category: Torrie, L S]]
[[Category: Wyatt, P G]]
[[Category: Acyltransferase]]
[[Category: Drug discovery]]
[[Category: Transferase]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA